Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2

Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the current coronavirus disease 2019 (COVID-19) pandemic. A major virulence factor of SARS-CoVs is the nonstructural protein 1 (Nsp1), which suppresses host gene expression by ribosome association. Here, we show that Nsp1 from SARS-CoV-2 binds to the 40S ribosomal subunit, resulting in shutdown of messenger RNA (mRNA) translation both in vitro and in cells. Structural analysis by cryo-electron microscopy of in vitro-reconstituted Nsp1-40S and various native Nsp1-40S and -80S complexes revealed that the Nsp1 C terminus binds to and obstructs the mRNA entry tunnel. Thereby, Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection. Thus, the structural characterization of the inhibitory mechanism of Nsp1 may aid structure-based drug design against SARS-CoV-2.
Funding Information
  • Boehringer Ingelheim Fonds (Ph.D. fellowship)
  • Deutsche Forschungsgemeinschaft (SFB/TRR-174)
  • Deutsche Forschungsgemeinschaft (BE1814/15-1)
  • Deutsche Forschungsgemeinschaft (BE1814/1-1)
  • Deutsche Forschungsgemeinschaft (CRC-1279)
  • Deutsche Forschungsgemeinschaft (CRC-1279)
  • Deutsche Forschungsgemeinschaft (SPP-1923)
  • Bundesministerium für Bildung und Forschung (RestrictSARS-CoV2)
  • University Ulm Medical Center (L.SBN.0150)
  • Deutsche Forschungsgemeinschaft (SPP-1923)
  • Deutsche Forschungsgemeinschaft (SP1600/4-1)